Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI

Fabrizio D'Ascenzo*, Umberto Benedetto, Matteo Bianco, Federico Conrotto, Claudio Moretti, Augusto D'Onofrio, Marco Agrifoglio, Antonio Colombo, Flavio Ribichini, Giuseppe Tarantini, Maurizio D'Amico, Stefano Salizzoni, Mauro Rinaldi, on behalf of the ITER Investigators, Alaide Chieffo, Gennaro Giustino, Tommaso Regesta, Massimo Napodano, Davide Gabbieri, Francesco SaiaCorrado Tamburino, Diego Cugola, Marco Aiello, Francesco Sanna, Alessandro Iadanza, Esmeralda Pompei, Pierluigi Stefàno, Antioco Cappai, Alessandro Minati, Mauro Cassese, Gian Luca Martinelli, Andrea Agostinelli, Rosario Fiorilli, Francesco Casilli, Maurizio Reale, Francesco Bedogni, Anna Sonia Petronio, Pierluigi Omedè, Antonio Montefusco, Rosa Alba Mozzillo, Roberto Bonmassari, Carlo Briguori, Armando Liso, Gennaro Sardella, Giuseppe Bruschi, Gino Gerosa, Francesco Romeo

*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

53 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI'. Together they form a unique fingerprint.

Medicine and Dentistry